Patent classifications
C07C225/22
Thermally activated delayed fluorescence material having red, green, or blue color, synthesis method thereof, and application thereof
The present disclosure relates to the field of organic light-emitting materials, and more particularly, to a thermally activated delayed fluorescence material having red, green, or blue color, a synthesis method thereof, and application thereof. The thermally activated delayed fluorescence material having red, green, or blue color has the following structural formula: ##STR00001## the present disclosure provides a novel thermally activated delayed fluorescence material having red, green, or blue color which has a lower singlet triplet energy level difference, a high RISC rate constant (kRISC), and a high photoluminescence quantum yield (PLQY). It has significant characteristics of a thermally activated delayed fluorescence material and a long service life that can be used in an electroluminescent display and a light-emitting equipment structure which are mass produced.
Thermally activated delayed fluorescence material having red, green, or blue color, synthesis method thereof, and application thereof
The present disclosure relates to the field of organic light-emitting materials, and more particularly, to a thermally activated delayed fluorescence material having red, green, or blue color, a synthesis method thereof, and application thereof. The thermally activated delayed fluorescence material having red, green, or blue color has the following structural formula: ##STR00001## the present disclosure provides a novel thermally activated delayed fluorescence material having red, green, or blue color which has a lower singlet triplet energy level difference, a high RISC rate constant (kRISC), and a high photoluminescence quantum yield (PLQY). It has significant characteristics of a thermally activated delayed fluorescence material and a long service life that can be used in an electroluminescent display and a light-emitting equipment structure which are mass produced.
Antibacterial hydrophilic compound and use thereof
The present disclosure provides an antibacterial hydrophilic compound. The antibacterial hydrophilic compound may react, induced by light through a hydrogen abstraction group in the structural formula thereof, with a C—H group and thus bind to a surface of a material having the C—H group (for example, chemical fibers such as polyester, chinlon, and the like; plastics, rubbers, and other similar materials), which can impart a durable antibacterial activity and hydrophilicity to the material. The antibacterial hydrophilic compound has a relatively strong binding force to the surface of the material without damaging the mechanical properties of the raw material. The present disclosure also provides a modified material that is modified by the antibacterial hydrophilic compound.
Polymerizable absorbers of UV and high energy visible light
Described are polymerizable high energy light absorbing compounds of formula I: ##STR00001##
wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, and X are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
Curcumin analogues as zinc chelators and their uses
This invention provides a compound having the structure ##STR00001##
wherein α, β, X, Y, and R.sub.1-R.sub.11 are defined herein. This invention also provides a pharmaceutical composition comprising the above compounds, a method of inhibiting the activity and/or levels of a matrix metalloproteinase (MMP), a method of inhibiting the production of a cytokine in a population of cells, a method of inhibiting the production of a growth factor in a population of cells, and a method of inhibiting NFκ-B activation in a population of cells.
Curcumin analogues as zinc chelators and their uses
This invention provides a compound having the structure ##STR00001##
wherein α, β, X, Y, and R.sub.1-R.sub.11 are defined herein. This invention also provides a pharmaceutical composition comprising the above compounds, a method of inhibiting the activity and/or levels of a matrix metalloproteinase (MMP), a method of inhibiting the production of a cytokine in a population of cells, a method of inhibiting the production of a growth factor in a population of cells, and a method of inhibiting NFκ-B activation in a population of cells.
Compounds and matrices for use in bone growth and repair
Compositions of small molecules, matrices, and isolated cells including methods of preparation, and methods for differentiation, trans-differentiation, and proliferation of animal cells into the osteoblast cell lineage were described. Examples of osteogenic materials that were administered to cells or co-cultured with cells are represented by compounds of Formula II, IV, and VI independently or preferably in combination with a matrix to afford bone cells. Small molecule-stimulated cells were also combined with a matrix, placed with a cellular adhesive or material carrier and implanted to a site in an animal for bone repair. Matrix pretreated with compounds of Formula II, IV, and VI were also used to cause cells to migrate to the matrix that is of use for therapeutic purposes.
Compounds and matrices for use in bone growth and repair
Compositions of small molecules, matrices, and isolated cells including methods of preparation, and methods for differentiation, trans-differentiation, and proliferation of animal cells into the osteoblast cell lineage were described. Examples of osteogenic materials that were administered to cells or co-cultured with cells are represented by compounds of Formula II, IV, and VI independently or preferably in combination with a matrix to afford bone cells. Small molecule-stimulated cells were also combined with a matrix, placed with a cellular adhesive or material carrier and implanted to a site in an animal for bone repair. Matrix pretreated with compounds of Formula II, IV, and VI were also used to cause cells to migrate to the matrix that is of use for therapeutic purposes.
ANTIBACTERIAL HYDROPHILIC COMPOUND
The present disclosure provides an antibacterial hydrophilic compound. The antibacterial hydrophilic compound may react, induced by light through a hydrogen abstraction group in the structural formula thereof, with a C—H group and thus bind to a surface of a material having the C—H group (for example, chemical fibers such as polyester, chinlon, and the like; plastics, rubbers, and other similar materials), which can impart a durable antibacterial activity and hydrophilicity to the material. The antibacterial hydrophilic compound has a relatively strong binding force to the surface of the material without damaging the mechanical properties of the raw material. The present disclosure also provides a modified material that is modified by the antibacterial hydrophilic compound.
POLYMERIZABLE ABSORBERS OF UV AND HIGH ENERGY VISIBLE LIGHT
Described are polymerizable high energy light absorbing compounds of formula I:
##STR00001##
wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, and X are as described herein. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.